Kalle Känd

Chief Executive Officer

Dr. Kalle Känd is the Chief Executive Officer (CEO) of MS Pharma since February 2020. Before that, he held the position of CEO in Acino International AG, Switzerland from 2016-2018 and Chief Commercial Officer (CCO) in 2014-2016.

Throughout his career, he has been in various commercial and strategy positions like VP Strategy Emerging Markets for Takeda; Regional Head of Strategy and Alliance Management for Nycomed Russia/CIS; and Director International Marketing for Nycomed. He has more than 20 years of experience in the international pharmaceutical industry, closed several M&A and licensing deals, divestments, and carve-outs. He has a proven track record in leading companies, sales, and marketing organizations in multiple geographical regions.

Kalle Känd studied medicine in Tartu and Helsinki University and received a Doctor of Medicine degree